44 related articles for article (PubMed ID: 34353608)
1. Dual targeting of DDX3 and eIF4A by the translation inhibitor rocaglamide A.
Chen M; Asanuma M; Takahashi M; Shichino Y; Mito M; Fujiwara K; Saito H; Floor SN; Ingolia NT; Sodeoka M; Dodo K; Ito T; Iwasaki S
Cell Chem Biol; 2021 Apr; 28(4):475-486.e8. PubMed ID: 33296667
[TBL] [Abstract][Full Text] [Related]
2. Intercepted Retro-Nazarov Reaction: Syntheses of Amidino-Rocaglate Derivatives and Their Biological Evaluation as eIF4A Inhibitors.
Zhang W; Chu J; Cyr AM; Yueh H; Brown LE; Wang TT; Pelletier J; Porco JA
J Am Chem Soc; 2019 Aug; 141(32):12891-12900. PubMed ID: 31310112
[TBL] [Abstract][Full Text] [Related]
3. RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer.
Wolfe AL; Singh K; Zhong Y; Drewe P; Rajasekhar VK; Sanghvi VR; Mavrakis KJ; Jiang M; Roderick JE; Van der Meulen J; Schatz JH; Rodrigo CM; Zhao C; Rondou P; de Stanchina E; Teruya-Feldstein J; Kelliher MA; Speleman F; Porco JA; Pelletier J; Rätsch G; Wendel HG
Nature; 2014 Sep; 513(7516):65-70. PubMed ID: 25079319
[TBL] [Abstract][Full Text] [Related]
4. Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with
Peters TL; Tillotson J; Yeomans AM; Wilmore S; Lemm E; Jiménez-Romero C; Amador LA; Li L; Amin AD; Pongtornpipat P; Zerio CJ; Ambrose AJ; Paine-Murrieta G; Greninger P; Vega F; Benes CH; Packham G; Rodríguez AD; Chapman E; Schatz JH
Clin Cancer Res; 2018 Sep; 24(17):4256-4270. PubMed ID: 29844128
[No Abstract] [Full Text] [Related]
5. Novel eIF4A1 inhibitors with anti-tumor activity in lymphoma.
Kayastha F; Herrington NB; Kapadia B; Roychowdhury A; Nanaji N; Kellogg GE; Gartenhaus RB
Mol Med; 2022 Sep; 28(1):101. PubMed ID: 36058921
[TBL] [Abstract][Full Text] [Related]
6. Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other Sarcomas.
Chang LS; Oblinger JL; Burns SS; Huang J; Anderson LW; Hollingshead MG; Shen R; Pan L; Agarwal G; Ren Y; Roberts RD; O'Keefe BR; Kinghorn AD; Collins JM
Mol Cancer Ther; 2020 Mar; 19(3):731-741. PubMed ID: 31848295
[TBL] [Abstract][Full Text] [Related]
7. Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species.
Pan L; Woodard JL; Lucas DM; Fuchs JR; Kinghorn AD
Nat Prod Rep; 2014 Jul; 31(7):924-39. PubMed ID: 24788392
[TBL] [Abstract][Full Text] [Related]
8. Broad anti-pathogen potential of DEAD box RNA helicase eIF4A-targeting rocaglates.
Obermann W; Azri MFD; Konopka L; Schmidt N; Magari F; Sherman J; Silva LMR; Hermosilla C; Ludewig AH; Houhou H; Haeberlein S; Luo MY; Häcker I; Schetelig MF; Grevelding CG; Schroeder FC; Lau GSK; Taubert A; Rodriguez A; Heine A; Yeo TC; Grünweller A; Taroncher-Oldenburg G
Sci Rep; 2023 Jun; 13(1):9297. PubMed ID: 37291191
[TBL] [Abstract][Full Text] [Related]
9. Update on Phytochemical and Biological Studies on Rocaglate Derivatives from Aglaia Species.
Agarwal G; Chang LS; Soejarto DD; Kinghorn AD
Planta Med; 2021 Oct; 87(12-13):937-948. PubMed ID: 33784769
[TBL] [Abstract][Full Text] [Related]
10. Remodeling natural products: chemistry and serine hydrolase activity of a rocaglate-derived β-lactone.
Lajkiewicz NJ; Cognetta AB; Niphakis MJ; Cravatt BF; Porco JA
J Am Chem Soc; 2014 Feb; 136(6):2659-64. PubMed ID: 24447064
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Eukaryotic Translation by the Antitumor Natural Product Agelastatin A.
McClary B; Zinshteyn B; Meyer M; Jouanneau M; Pellegrino S; Yusupova G; Schuller A; Reyes JCP; Lu J; Guo Z; Ayinde S; Luo C; Dang Y; Romo D; Yusupov M; Green R; Liu JO
Cell Chem Biol; 2017 May; 24(5):605-613.e5. PubMed ID: 28457705
[TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibitors of PCSK9. SAR investigations of head and amine groups.
Aspnes GE; Coffey SB; Darout E; Dechert-Schmitt AM; Dullea RG; Kamlet AS; Limberakis C; Londregan AT; McClure KF; Menhaji-Klotz E; Piotrowski DW; Polivkova J; Raymer B; Ruggeri RB; Salatto CT; Tu M; Wei L; Xiao J
Bioorg Med Chem Lett; 2023 Aug; 92():129394. PubMed ID: 37379958
[TBL] [Abstract][Full Text] [Related]
13. Targeting RNA structures with small molecules.
Childs-Disney JL; Yang X; Gibaut QMR; Tong Y; Batey RT; Disney MD
Nat Rev Drug Discov; 2022 Oct; 21(10):736-762. PubMed ID: 35941229
[TBL] [Abstract][Full Text] [Related]
14. 1-Aminomethyl SAR in a novel series of flavagline-inspired eIF4A inhibitors: Effects of amine substitution on cell potency and in vitro PK properties.
Nilewski C; Michels TD; Packard GK; Xiang AX; Sprengeler PA; Eam B; Fish S; Thompson PA; Wegerski CJ; Nevarez A; Clarine J; Sperry S; Ernst JT; Reich SH
Bioorg Med Chem Lett; 2021 Sep; 47():128111. PubMed ID: 34353608
[TBL] [Abstract][Full Text] [Related]
15. Strategic Diastereoselective C1 Functionalization in the Aza-Rocaglamide Scaffold toward Natural Product-Inspired eIF4A Inhibitors.
Nilewski C; Michels TD; Xiang AX; Packard GK; Sprengeler PA; Eam B; Fish S; Thompson PA; Wegerski CJ; Ernst JT; Reich SH
Org Lett; 2020 Aug; 22(16):6257-6261. PubMed ID: 32806219
[TBL] [Abstract][Full Text] [Related]
16. Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells.
Wilmore S; Rogers-Broadway KR; Taylor J; Lemm E; Fell R; Stevenson FK; Forconi F; Steele AJ; Coldwell M; Packham G; Yeomans A
Cell Mol Life Sci; 2021 Sep; 78(17-18):6337-6349. PubMed ID: 34398253
[TBL] [Abstract][Full Text] [Related]
17. Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase.
Ernst JT; Thompson PA; Nilewski C; Sprengeler PA; Sperry S; Packard G; Michels T; Xiang A; Tran C; Wegerski CJ; Eam B; Young NP; Fish S; Chen J; Howard H; Staunton J; Molter J; Clarine J; Nevarez A; Chiang GG; Appleman JR; Webster KR; Reich SH
J Med Chem; 2020 Jun; 63(11):5879-5955. PubMed ID: 32470302
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
